AI assistant
Wanbury Limited — Board/Management Information 2021
Feb 6, 2021
60248_rns_2021-02-06_13e49807-68c6-496f-bc75-bc8fa9f30b0a.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Wanbury limited
Re~d. Office : BSEL Tech Park, B-wing 10' Floor, Sector-30 A, Opp. Vashi Railway Station, Vashi Navi Mumbai 400 703 Maharashtra, INDIA

Tel. : +91-22-6794 2222 +91-22-7196 3222 Fax : +91-22-6794 2111/333 CIN L51900MH1988PLC048455 Email : [email protected] Website: www.wanbury.com
6th February, 2021
| To, | To, |
|---|---|
| The Manager - Listing Department, | The Manager - Listing Department, |
| BSE Limited, | National Stock Exchange of India Ltd., |
| Phiroze Jeejeebhoy Towers, | Exchange Plaza, Plot No. C/1, G-Block, |
| Dalal Street, | Bandra-Kurla Complex, Bandra (East), |
| Mumbai - 400 001. | Mumbai - 400 051. |
| Scrip Code: 524212 | Symbol: WANBURY |
Dear Sir/ Madam,
Sub.: Outcome of the Board Meeting held on 6th February, 2021
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. 6th February, 2021 has inter-alia considered and approved the following which shall be subject to the approval of Shareholders of the Company and other applicable Regulatory Authorities as the case may be:
i) The appointment of Mr. Binod Chandra Maharana (DIN: 07095774) as an Additional Director of the Company, with effect from 6th February, 2021 and to hold office as such upto the date of the 33rd Annual General Meeting of the Company, in terms of Sections 149, 152 and 161 of the Companies Act, 2013 read with the Rules made thereunder and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The first term of Mr. Binod Chandra Maharana (DIN: 07095774) as Non-Executive Independent Director of the Company, shall be for a period of one year with effect from 6th February, 2021 up to 5th February, 2022 (both days inclusive). During his tenure as an Independent Director of the Company, Mr. Binod Chandra Maharana shall not be liable to retire by rotation, in terms of Section 149(13) of the Companies Act, 2013.
The brief profile of Mr. Binod Chandra Maharana (DIN: 07095774) is enclosed herewith as Annexure -I.
ii) The appointment of Dr. Manisha Juvekar (DIN: 09053979) as an Additional Director of the Company, with effect from 6th February, 2021 and to hold office as such upto the date of the 33ni Annual General Meeting of the Company, in terms of Sections 149, 152 and 161 of the Companies Act, 2013 read with the Rules made thereunder and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The first term of Dr. Manisha Juvekar (DIN: 09053979) as Non-Executive Independent Director of the Company, shall be for a period of one year with effect from 6th February, 2021 up to 5th February, 2022 (both days inclusive). During her tenure as an Independent Director of the Company, Dr. Manisha Juvekar shall not be liable to retire by rotation, in terms of Section 149(13) of the Companies Act, 2013.

The brief profile of Dr. Manisha Juvekar (DIN: 09053979) is enclosed herewith as Annexure -II
The Meeting of the Board of Directors commenced at 11:45 A.M. and concluded at 12:45 P.M. We request you to take this information on your records & kindly acknowledge the receipt of the same.
Thanking you,
Yours truly, For Wan bury Limited \ ' il \1 ~ I ,[,!;!WV"'"' .f/U ~.f JiteR«rtfJ. Gandhi Company Secretary
Encl .. : afa.

ANNEXURE-I
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 concerning the appointment of Mr. Binod Chandra Maharana (DIN: 07095774) as an Additional Director (Non-executive Independent Director).
| Disclosure requirements | Details |
|---|---|
| Date of Appointment and TermsofAppointment | Mr. Binod Chandra Maharana (DIN: 07095774) has beenappointedasanAdditionalDirector(Non-executiveIndependent Director) of the Company w.e.f. 6th February,2021.He shall hold the office for a period of one year. |
| Brief Profile | Mr. Binod Chandra Maharana holds a bachelor's degree incommerce (hons) from Berhampur University. He is aqualified Chartered Accountant from the ICAI and holdscertificate of practise. He is currently designated as a seniorpartner of M/s S. Ramanand Aiyar & Co, for overseeing theAudit & Financial Services Divisions of the firm at Mumbai.He has more than 25 years of post qualification experienceand is proficient in dealing with statutory audits of largecorporate, bank audits, internal audits of manufacturing andservice sectors, internal and concurrent audit of financialinstitutions. He has experience of conducting business inGulf and Middle East. In the past, he has acted in thecapacity of a chief internal auditor and finance controller toM/S Al Ayad International LLC, Oman, belongings to AlKhwaja group company having business establishment atOman, Dubai, Jordan, India, Egypt and US on variousaccounting and business issues. Prior to this, he wasmanager of M/ s. K. S. Aiyar & Co. |
| DisclosureofRelationshipbetweenDirectors | Mr. Binod Chandra Maharana is not related to any of theDirectors of the Company. |


ANNEXURE-11
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 concerning the appointment of Dr. Manisha Juvekar (DIN: 09053979) as an Additional Director (Non-executive Independent Director).
| Disclosure requirements | Details |
|---|---|
| Date of Appointment and Terms ofAppointment | Dr. Manisha Juvekar (DIN: 09053979) has been appointed asanAdditionalDirector(Non-executiveIndependentDirector) of the Company w.e.f. 6th February, 2021.She shall hold the office for a period of one year. |
| Brief Profile''.f~ | Dr. Manisha Juvekar holds a master's degree in Pediatricsfrom Lokmariya Tilak Medical College, Mumbai. She has20 years of experience in the field of Medical and Pharmafield. She is currently consultant at Dr. D.Y. Patil Hospitaland J uvekar Hospital. |
| DisclosureofRelationshipbetweenDirectors | Dr. Manisha Juvekar is not related to any of the Directors ofthe Company. |
